Target intelligence / Profile preview

Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial (CHCHD10)

Target
CHCHD10
Molecular classification
Mitochondrial protein, Structural mitochondrial protein (MICOS complex component), Other
01

Overview

Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial (CHCHD10) is a mitochondrial inner membrane protein highly enriched at cristae junctions, encoded by the CHCHD10 gene on chromosome 22. CHCHD10 is a component of the MICOS complex, a key regulator of mitochondrial inner membrane morphology and cristae formation. The protein’s structure features a nonstructured N-terminal region, a hydrophobic helix, and a C-terminal CHCH domain with two disulfide bonds. Functional studies indicate that CHCHD10 is involved in maintaining cristae morphology, mitochondrial respiration, and can influence apoptosis and mitochondrial genome stability. Mutations in CHCHD10 are linked to a spectrum of neurodegenerative disorders, most notably ALS and frontotemporal dementia, through disruption of mitochondrial dynamics, respiratory function, and cellular stress responses.

Other names
CHCHD10Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrialProtein N27C7-4C22orf16MIX17AFTDALS2IMMDSMAJMIX17 homolog A
02

Biological functions

Maintenance of mitochondrial cristae morphologyRegulation of mitochondrial organization and functionRegulation of oxidative phosphorylationRegulation of mitochondrial respiration (especially under hypoxia)Can inhibit apoptosis via blocking cytochrome c releaseModulation of synaptic plasticityInvolved in cell migration and apoptosis
03

Disease associations

Neurodegenerative diseaseAmyotrophic lateral sclerosis (ALS)Frontotemporal dementia (FTD)Parkinson’s disease (PD)Mitochondrial myopathyCharcot-Marie-Tooth disease type 2Spinal muscular atrophy, Jokela type (SMAJ)Other neurological disorders
04

Safety considerations

Pathogenic mutations can cause broad neurodegenerative phenotypes, indicating potential off-target effects if therapeutically manipulatedUnclear consequences of altering mitochondrial cristae structure or integrity in non-diseased tissues
05

Biomarkers

Mutations in CHCHD10 gene (e.g., p.R15L, p.S59L, p.Q82X) used for diagnosis or prognosis in ALS/FTD spectrum disordersPresence of CHCHD10 aggregates in neurons for certain ALS cases

Beyond the preview

Go deeper on Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial (CHCHD10).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial (CHCHD10).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call